Pyronaridine-artesunate and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a randomized controlled non-inferiority trial

Malaria Journal
Johanna M RothPetra F Mens

Abstract

Pyronaridine-artesunate is a novel artemisinin-based combination therapy. The efficacy and safety of pyronaridine-artesunate were compared with artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in children. This phase III open-label randomized controlled non-inferiority trial was conducted in Western Kenya. Children aged 6 months to ≤ 12 years with a bodyweight > 5 kg and microscopically confirmed P. falciparum malaria were randomly assigned in a 1:1 ratio to orally receive pyronaridine-artesunate or artemether-lumefantrine, dosed according to bodyweight, for 3 days. Of 197 participants, 101 received pyronaridine-artesunate and 96 received artemether-lumefantrine. The day-28 adequate clinical and parasitological response in the per-protocol population, PCR-corrected for reinfections, was 98.9% (93/94, 95% CI 94.2-99.8) for pyronaridine-artesunate and 96.4% (81/84, 95% CI 90.0-98.8) for artemether-lumefantrine. Pyronaridine-artesunate was found to be non-inferior to artemether-lumefantrine: the treatment difference was 2.5% (95% CI - 2.8 to 9.0). Adverse events occurred in 41.6% (42/101) and 34.4% (33/96) of patients in the pyronaridine-artesunate group and the artemether-lumefantrine group...Continue Reading

References

Jun 13, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P RingwaldL K Basco
May 29, 1999·The American Journal of Tropical Medicine and Hygiene·R PriceF Nosten
Feb 19, 2000·Antimicrobial Agents and Chemotherapy·F EzzetN J White
Feb 5, 2010·The Lancet Infectious Diseases·Stephen J RogersonSteven R Meshnick
Apr 27, 2010·Lancet·Francois Henri Nosten
Oct 12, 2011·Current Opinion in Infectious Diseases·Florian KurthMichael Ramharter
Apr 6, 2012·The New England Journal of Medicine·Ronnatrai RueangweerayutUNKNOWN Pyronaridine–Artesunate Study Team
Aug 11, 2012·Malaria Journal·Simon L CroftHan-Jong Rim
Jul 31, 2014·The New England Journal of Medicine·Elizabeth A AshleyUNKNOWN Tracking Resistance to Artemisinin Collaboration (TRAC)
Dec 1, 2015·Scientific Reports·Mallika ImwongArjen M Dondorp
Jun 24, 2016·Microbiology Spectrum·Rick M Fairhurst, Arjen M Dondorp

❮ Previous
Next ❯

Citations

Jan 9, 2019·The Cochrane Database of Systematic Reviews·Joseph Pryce, Paul Hine
Nov 28, 2020·Pharmacogenomics·Adebanjo J AdegbolaOluseye O Bolaji
Dec 9, 2020·The Cochrane Database of Systematic Reviews·Sabine BélardFlorian Kurth
May 14, 2021·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Edgard D DabiraJane Achan

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping

Clinical Trials Mentioned

NCT02411994

Software Mentioned

Stata

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.